Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AGILENT TECHNOLOGIES, INC.

(A)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

RareCyte, Inc. announced that it has received $24.046147 million in funding from Arboretum Ventures LLC, F Prime, Inc., Agilent Technologies, Inc., HealthQuest Capital, 5AM Venture Management, LLC

09/10/2021 EDT

On September 10, 2021, RareCyte, Inc. closed the transaction. The company has received $46,147 in its second and final tranche closing. The company raised a total of $24,046,147 in the transaction from 27 investors.


© S&P Capital IQ 2021
All news about AGILENT TECHNOLOGIES, INC.
10/14VC DAILY : Sprinter Health Collects $33 Million to Join Home-Healthcare Race
DJ
10/13AGILENT TECHNOLOGIES : Eli Lilly Get FDA's OK for Assay to Identify Early Breast Cancer
MT
10/13AGILENT TECHNOLOGIES : Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 phar..
BU
10/13Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-..
CI
10/12Akadeum Life Sciences, Inc. announced that it has received $17.5 million in funding fro..
CI
10/04AGILENT TECHNOLOGIES, INC. : Ex-dividend day for
FA
09/28AGILENT TECHNOLOGIES : Announces Thought Leader Award to Bernhard Lendl at the TU Wien (Vi..
BU
09/24AGILENT TECHNOLOGIES : Dr. Mikael Dolsten Named to Agilent Board of Directors, Pfizer exec..
AQ
09/23AGILENT TECHNOLOGIES : Pfizer executive brings strong scientific and medical expertise to ..
PU
09/23AGILENT TECHNOLOGIES, INC. : Change in Directors or Principal Officers, Regulation FD Disc..
AQ
More news
Analyst Recommendations on AGILENT TECHNOLOGIES, INC.
More recommendations
Financials (USD)
Sales 2021 6 317 M - -
Net income 2021 1 075 M - -
Net Debt 2021 1 485 M - -
P/E ratio 2021 44,6x
Yield 2021 0,49%
Capitalization 47 110 M 47 110 M -
EV / Sales 2021 7,69x
EV / Sales 2022 7,16x
Nbr of Employees 16 700
Free-Float 99,7%
Chart AGILENT TECHNOLOGIES, INC.
Duration : Period :
Agilent Technologies, Inc. Technical Analysis Chart | A | US00846U1016 | MarketScreener
Technical analysis trends AGILENT TECHNOLOGIES, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 155,62 $
Average target price 172,40 $
Spread / Average Target 10,8%
EPS Revisions
Managers and Directors
Michael R. McMullen President, Chief Executive Officer & Director
Robert W. McMahon Chief Financial Officer & Senior Vice President
Koh Boon Hwee Non-Executive Chairman
Darlene J. S. Solomon Chief Technology Officer & Senior Vice President
Katharine Knobil Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
AGILENT TECHNOLOGIES, INC.31.34%47 110
THERMO FISHER SCIENTIFIC26.25%232 943
DANAHER CORPORATION36.93%220 224
INTUITIVE SURGICAL, INC.23.32%120 050
SIEMENS HEALTHINEERS AG37.92%75 570
EDWARDS LIFESCIENCES CORPORATION21.77%71 683